David Scott Tomsche - 15 Aug 2024 Form 4 Insider Report for IMMUCELL CORP /DE/ (ICCC)

Reporting relationship: Director
Issuer ticker: ICCC
Reported as of: 15 Aug 2024
Net transaction value: +$36,719
SEC form: 4
Accepted by SEC: 19 Aug 2024, 13:04:06 UTC
Prior SEC filing: 06 Sep 2023
Next SEC filing: 22 Aug 2024
Source filing: View source filing
Reporting owner signature: /s/ Michael F Brigham Attorney-in-Fact

Key filing fact

David Scott Tomsche filed Form 4 for IMMUCELL CORP /DE/ (ICCC) on 19 Aug 2024.

Key facts

This page summarizes David Scott Tomsche's Form 4 filing for IMMUCELL CORP /DE/ (ICCC).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 19 Aug 2024, 13:04.

Change

Previous filing in this sequence was filed on 06 Sep 2023.
Current net transaction value: +$36,719.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ICCC transaction

Common stock $0.10 per value per share

Disposed to Issuer

Transaction value: $7,195
Shares: +2,017
Change %: +1.9%
Price: $3.57
Shares after: 105,623
Date: 15 Aug 2024
Ownership: Direct

ICCC transaction

Common stock $0.10 per value per share

Disposed to Issuer

Transaction value: $17,883
Shares: +4,811
Change %: +4.6%
Price: $3.72
Shares after: 110,434
Date: 16 Aug 2024
Ownership: Direct

ICCC transaction

Common stock $0.10 per value per share

Disposed to Issuer

Transaction value: $11,641
Shares: +3,172
Change %: +2.9%
Price: $3.67
Shares after: 113,606
Date: 19 Aug 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1. This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .